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 Abnormalities of the thyroid gland in the form of enlargement of the thyroid gland 
are called a goiter. Goiter is divided into two types, namely toxic and non-toxic 
diffuse goiter. Diagnosis could be done with thyroid scan (in vivo) and test for 
thyroid hormone value (in vitro). Thyroid scan is applied by giving injection of 
99mTc Pertechnetate as much as 2 - 5 mCi intravenally in the arm and then thyroid 
gland and salivary glands imaging were conducted in the fifth minute, tenth minute 
and fifteenth minute using gamma camera. Thyroid hormones test in blood is done 
with radioimmunoassay method. The same pattern showed the accumulation polad 
of the radioactive number from quotation of salivary glands. The accumulation 
percentage activity of 99mTc Pertechnetate in thyroid gland for the case of toxic 
diffuse goiter is larger than the case of non-toxic diffuse goiter. The results of this 
study indicate that the predictors for the case of toxic diffuse goiter could be 
characterized by high thyroid uptake which the the value of T3 hormone  3.3 ng/dl, 
the value of T4 hormone  165 nmol/l,  and the value of TSH hormone 
 0.2 µIU/ml. While the case of non-toxic diffuse goiter could be characterized by 
low thyroid uptake which the value of  T3 hormone  1.2 ng/dl, the value of T4
hormone  90 nmol/l, and the value of TSH hormone  1.8 µIU/ml.  
© 2012 Atom Indonesia. All rights reserved
 
INTRODUCTION∗ 
 
Nuclear medicine studies are more likely to 
be used to evaluate a wide range of congenital 
conditions but also can be helpful for evaluating 
acquired conditions such as infection, cancer, and 
trauma [1]. One of the organs that can be studied 
with nuclear medicine studies is the thyroid gland. 
Assessment of thyroid gland function in nuclear 
medicine can be used to establish the diagnosis               
of dysfunction, such as hyperthyroidism, 
hypothyroidism, thyroiditis, thyroid nodules and 
thyroid cancer abnormality [2].  
Kandeel et al [3] studied post-operative 
patients who showed indications of 
hyperthyroidism, the uptake in the thyroid tissue 
remaining catch fewer radiopharmaceutical 
compared with salivary glands. Stephen's et al [4]  
reported the value of the average radiophar-
maceutical uptake in the parotid gland and the 
submandibular gland were 0.30 % and 0.17 %  
respectively. The study was carried out for                
15 minutes, and the result showed that the 
                                                
∗ Corresponding author. 
   E-mail address: novaliapeve@student.undip.ac.id  
radiopharmaceutical activity in the parotid gland 
was still increasing, while in the submandibular 
gland has reached the highest peak or already 
declining.  
Abnormalities of the thyroid gland may 
enlarge gland and changes the work function of the 
normal state. Normal thyroid gland function is 
characterized by the percentage uptake (catch) 
radiopharmaceutical approximately 1.6 to 7.6 % 
[5]. This study was conducted in patients with               
thyroid gland disorders, both toxic and non toxic 
diffuse goiter. 
 
 
EXPERIMENTAL METHODS 
 
The number of patients studied were 70 
people with diffuse goiter cases (35 toxic and 35 
non toxic) who underwent examination in vivo 
(thyroid scan) and in vitro (test hormone, T3, T4 
and TSH in the blood).   
Radiopharmaceutical used for in vivo is 
99mTc Pertechnetate. 2-5 mCi of 99mTc 
Pertechnetate is injected through an intravenous, 
and then imaging was performed using a gamma 
Atom Indonesia 
 
 Atom Indonesia Vol. 38  N . 1  (2012) ……………….. 
22 
Atom Indonesia Vol. 38  No. 1  (2012)  22 - 28 
 
N.P. Viantri, et al / Atom Indonesia Vol. 38 No. 1  (2012)  22 - 28 
 
 
camera. Imaging time variation of the thyroid gland 
and salivary glands were conducted at 5, 10 and 15 
minutes after the injection.  
Radiopharmaceutical accumulation in the 
thyroid gland are called the thyroid uptake. Thyroid 
uptake calculations can be done by manual 
calculation [6].  
Count values of thyroid gland obtained 
from the ROI (Region of Interest) in the thyroid 
gland with a size corresponding to the shape of 
the gland. Background count is obtained from the 
ROI outside the thyroid gland with a size of 1 x 1 
cm. Salivary glands were examined by ROI footage, 
on the left and right parotid gland with a size of                   
1.5 x 1.5 cm, on the left and right submandibular 
gland and the sublingual gland with the size                    
1 x 1 cm.  
Figure 1 shows the image before and after it 
is created ROI. 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Manufacture of ROI to get the value of the count. (1) 
Right parotid gland, (2) Left parotid gland, (3) Right 
submandibular gland, (4) Left submandibular gland, (5) 
Sublingual gland, (6) The thyroid gland, (7) Background. 
 
In vitro techniques used to determine levels of 
thyroid hormones in the blood. Radioisotopes 125I 
is mixed with the kit farmaka and blood serum of 
patients and then enumerated using a gamma 
counter [7]. The results of in vitro examination                
is the thyroid hormone (T3, T4 and TSH) in blood. 
From both of the technical tests, further correlation 
was searched using diagnostic tests. 
Diagnostic test consists of the gold standard 
of thyroid scan from in vivo technique, and 
examination test of the thyroid hormone from                         
in vitro. 
The both of these techniques were compared 
with the Cut of Point value (COP). COP is an index 
that is used as the boundary between normal and 
abnormal from the case, or the limit value of 
positive test results and negative test results. COP 
value is determined based on reference values from 
the results of examination [8]. Then, the                 
next step is determine diagnostic value with                    
2 x 2 diagnostic studies table. The table consists of 
the gold standard and test results, which produce 
some value, such as true positive, false positive, 
false negative and true negative [9]. All of the 
value can be used to determine the sensitivity and 
specificity values by manual calculation.  
A function of sensitivity and specificity 
value can be used to found the correlation of these 
examination techniques using Receiver Operating 
Characteristic curve (ROC). The point of 
intersection between sensitivity and spesificity 
value are called a cutoff. Cutoff with high 
sensitivity values can be used as a decision 
making process for the purpose of treatment and 
care of patients, whereas the cutoff with a high 
specificity value can be used as the final stage of 
diagnosis [8]. 
 
 
RESULTS AND DISCUSSION 
 
The thyroid uptake 
 
The mean changes in the thyroid uptake 
percentage for the toxic and non-toxic diffuse goiter 
which occurred at 5, 10 and 15 minutes after 
radiopharmaceutical injection was shown in Fig. 2. 
 
 
 
 
Figure 2 showed that the both cases had a 
mean percentage of 99mTc-pertechnetate uptake in 
the thyroid gland were increasing for a longer              
time interval. Since the 99mTc pertechnetate is not 
absorbed by the thyroid gland, so it can follow the 
body's metabolic processes. Percentage uptake for 
toxic diffuse goiter is greater than non-toxic 
diffuse goiter case. This is due to the hiperfunction 
performance of the thyroid gland for the toxic 
diffuse goiter case. 
23
Fig. 2. The mean change of uptake percentage for toxic and non-
toxic diffuse goiter. 
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The accumulation count of 99mTc 
pertechnetate on salivary glands 
 
Average value of the radioactivity 
accumulation in the salivary glands for toxic diffuse 
goiter were shown in Fig. 3 and Fig. 4.  
 
 
 
 
 
 
Fig. 4. The mean change in the accumulation count of 
radiopharmaceutical in the salivary glands for non-toxic             
diffuse goiter. 
Between the toxic and non toxic diffuse goiter 
have some difference. The difference lies in the 
accumulation count of radiopharmaceutical between 
submandibular and parotid gland. In toxic              
diffuse goiter, many radiopharmaceutical activity 
accumulates in the thyroid gland so that the 
radiopharmaceutical is only slightly towards the 
salivary glands. It's different for non-toxic diffuse 
goiter, radiopharmaceutical activity uniformly 
distributed in each gland. The differences of 99mTc 
Pertechnetate accumulation count obtained from the 
manufacture of ROI in the salivary glands depends 
on the size and performance (function) gland.  
The accumulation activity of 99mTc 
pertechnetate in thyroid gland 
In this research, the value count of 1 mCi 
99mTc Pertechnetate by a gamma camera was 
equivalent to 261,111 cpm. Figure 5 shows the 
number of radiopharmaceutical activity in the 
thyroid gland at 5, 10 and 15 minutes. 
 
 
Fig. 5. Percentage of radiopharmaceutical activity in the thyroid 
gland of patients for toxic and non-toxic diffuse goiter. 
 
The calculation of this activity aims to  
determine the activity of 99mTc -pertechnetate in the 
thyroid gland from a total injection. From Fig. 5, it 
can be seen that toxic diffuse goiter is demonstrated 
in patients 2, 3, 4, 6, 7, 8, 9, 10, 16 and 19, while the 
other is non-toxic diffuse goiter. The results 
obtained by calculating the mean value of the 
accumulated percentage of  99mTc pertechnetate 
showed that the activity in toxic diffuse goiter larger 
than non-toxic diffuse goiter.  In toxic diffuse goiter 
at 5,10 and 15 minutes were 9.89, 12.22, and 13.85 % 
respectively, while for  non-toxic diffuse goiter at 5, 
10 and 15 minutes were at 1.02, 1.05 and 1.11 % 
respectively. 
The differences of accumulation from 99mTc 
Pertechnetate activity is depending on the size of the 
gland as well as the ability (function) gland.               
The size of the thyroid gland for toxic diffuse 
goiter is larger and more responsive than the 
thyroid gland for non-toxic diffuse goiter.  
 
 
Correlation of thyroid hormone levels and 
thyroid uptake 
This study present thyroid uptake value and 
hormone value (T3, T4 and TSH hormones in               
the blood). Normal T3 hormone ranged               
24 
Fig. 3. The mean change in the accumulation count of
radiopharmaceutical in the salivary glands for toxic diffuse
goiter. 
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from 1.00 to 3.00 ng/dl, normal T4 hormone ranged 
from 55 to 170 nmol/l and normal TSH hormone 
ranged from 0.27 to 3.75 µIU/ml [5]. 
 
 
The case of toxic diffuse goiter 
 
Correlation of thyroid uptake with T3  
hormone 
 
Correlation of thyroid uptake with T3 
hormone can be determined using the table COP 
analysis, the ROC curve and the curve of sensitivity 
and specificity. COP values used in this correlation  
range from 1.9 to 4.2 with interval 0.1. Figure 6 
shows an uneven distribution of patient data at each 
COP indexes that have been determined. 
 
 
Fig. 6. Sensitivity and (1-specificity) of diagnostic tests 
between the thyroid uptake and T3 hormone. 
 
 
Fig. 7. The curve of sensitivity and specificity of diagnostic 
tests between the thyroid uptake and T3 hormone. 
 
   
 From Fig. 7, it can be seen on  the cut off 
values at the point 15 on the COP ≥ 3.3 that the 
sensitivity, specificity, positive and negative 
expected value were 71, 71, 79 and 63 % 
respectively. Optimal cutoff point was used as a 
benchmark determination of patients diagnosed as 
having case of toxic diffuse goiter with high thyroid 
uptake and T3 hormone  3.3 ng / dl.  
 
 
Correlation of thyroid uptake with T4  
hormone 
COP values are used to determine correlation 
of thyroid uptake with T4 hormone was 85 to 220   
with interval 5. The correlation between sensitivity 
and specificity values of COP calculation is 
described in the form of curves such as Fig. 8.              
It can be seen that some sensitivity and specificity 
values were in the same range, therefore not all 
points were formed in the surrounding withdrawal 
line.  
 
Fig. 8. Sensitivity and (1-specificity) of diagnostic test between 
the thyroid uptake and T4 hormone. 
 
 
 
 
Fig. 9. The curve of sensitivity and specificity of diagnostic 
tests between the thyroid uptake and T4 hormone. 
Cutoff values obtained from Fig. 9 at the 
point 17 on the COP  165 showed that the 
sensitivity, specificity, positive and negative 
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expected value were 71, 71, 79 and 63 % 
respectively. Optimal cutoff point was used as a 
benchmark determination of patients diagnosed with 
toxic diffuse goiter with high thyroid uptake and T4 
hormone  165 nmol/l, then the patient has high 
possibility had toxic diffuse goiter. 
 
 
Correlation of thyroid uptake with TSH 
hormone 
COP value are used in this correlation value 
from 0.09 to 0.33 with interval 0.01. The correlation 
between sensitivity and specificity values of COP 
calculation is described in the form of curves such 
as Fig. 10. 
 
 
Fig. 10. Sensitivity and (1-specificity) of diagnostic test 
between the thyroid uptake and TSH hormone. 
 
 
Fig. 11. The curve of sensitivity and specificity of diagnostic 
tests between the thyroid uptake and TSH hormone. 
 
Cutoff value obtained from Fig. 11 at the 
point 12 on the COP  0.2 showed that the 
sensitivity, specificity, positive and negative 
expected value were 81, 79, 85 and 73 % 
respectively. Optimal cutoff point can be used as a 
benchmark determination of patients diagnosed with 
toxic diffuse goiter with high thyroid uptake and 
TSH hormone  0.2 µIU/ml, then the patient should 
take the treatment for this case. 
 
The case of non-toxic diffuse goiter 
 
Correlation of thyroid uptake with T3 
hormone 
 
COP value are used to determine correlation 
of thyroid uptake with T3 hormone is 0.55 to               
1.6 with interval 0.05. From the value of COP, then 
it is made the ROC curve as in Fig. 12.  
 
 
Fig. 12. Sensitivity and (1-specificity) of diagnostic tests 
between the thyroid uptake and T3 hormone. 
 
 
Fig. 13. The curve of sensitivity and specificity of diagnostic 
tests between the thyroid uptake and T3 hormone. 
 
Curve intersection point of sensitivity and 
specificity of diagnostic tests between the thyroid 
uptake with T3 hormone are shown in Fig. 13. Based  
on Fig. 13, it can be seen on cutoff value at the point 
14 on COP ≥ 1.2 that the sensitivity, specificity, 
positive and negative expected value were 64,               
69, 78 and 53 % respectively. Optimal cutoff point 
can be used as a benchmark determination of 
patients diagnosed. If a person acquired with a low 
26 
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thyroid uptake and T3 hormone ≥ 1.2 ng/dl, the 
patient can be diagnosed as non-toxic diffuse goiter. 
 
 
Correlation of thyroid uptake with T4 
hormone 
 
COP value are used to determine correlation 
of thyroid uptake with T4 hormone is 45 to 130 with 
interval 5. The results of calculation of sensitivity 
and specificity values of COP values shown                  
in Fig. 14. 
 
 
 
Fig. 14. Sensitivity and (1-specificity) of diagnostic test 
between the thyroid uptake and T4 hormone. 
 
 
 
Fig. 15. The curve of sensitivity and specificity of diagnostic 
tests between the thyroid uptake and T4 hormone. 
 
Curve intersection point of sensitivity and 
specificity of diagnostic tests between the thyroid 
uptake with T4 hormone are shown in Fig. 15.                   
It shows the cutoff value obtained at the point 10 on 
COP ≥ 90 that the sensitivity, specificity, positive 
and negatif expected value were 64, 69, 78 and               
53 % respectively. If someone is detected with low 
thyroid uptake and T4 hormone ≥ 90 nmol/l, it can 
be diagnosed as non-toxic diffuse goiter. 
Correlation of thyroid uptake with TSH 
hormone 
 
COP value are used to determine correlation 
of thyroid uptake with TSH hormone were in the  
range 0.6 to 3.8 with interval 0.2. The results of 
calculation of sensitivity and specificity values of 
COP values shown in Fig. 16.  
 
 
 
Fig. 16. Sensitivity and (1-specificity) of diagnostic test 
between the thyroid uptake and TSH hormone. 
 
 
 
Fig. 17. The curve of sensitivity and specificity of diagnostic 
tests between the thyroid uptake and TSH hormone. 
 
Cutoff value obtained from Fig. 17 at the 
point 7 on COP ≤ 1.8 showed that the sensitivity, 
specificity, positive and negative expected value 
were 64, 77, 82 and 56 % respectively.  
Optimal cutoff point can be used as a 
benchmark so when someone is detected with low 
thyroid  uptake and TSH hormone ≤ 1.8 µIU/ml, it 
can be diagnosed as non-toxic diffuse goiter. 
 
 
CONCLUSION 
 
From this research  it can be concluded as 
follows: 
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The average value of radiopharmaceutical 
uptake increased along with increasing scan                     
time of 5, 10 and 15 minutes. 
The radiopharmaceutical accumulation on 
parotid and submandibular glands for toxic               
diffuse goiter is lower than  non-toxic diffuse 
goiter. 
The accumulation of radiopharmaceutical 
99mTc - Pertechnetate in toxic diffuse goiter is 
larger than non-toxic case. 
The case of toxic diffuse goiter                          
could be characterized by high thyroid uptake, 
which the value of T3 hormone  3.3 ng/dl,                     
the value of T4 hormone  165 nmol/l, and the               
value of TSH hormone  0.2 µIU/ml. While                    
the case of non-toxic diffuse goiter could                              
be characterized by low thyroid uptake, which               
the value of T3 hormone  1.2 ng/dl, the value                     
of T4 hormone  90 nmol/l and the value of                 
TSH hormone  1.8 µIU/ml  
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